3963 Maple Avenue
Suite 350
Dallas, TX 75219
United States
972 499 3350
https://instilbio.com
Sector(es): Healthcare
Sector: Biotechnology
Empleados a tiempo completo: 49
Nombre | Título | Paga | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Bronson Crouch | Chairman & CEO | 1,14M | N/A | 1973 |
Dr. Sandeep Laumas M.D. | CFO & Chief Business Officer | 741,52k | N/A | 1969 |
Dr. Mark E. Dudley Ph.D. | Chief Scientific Officer | N/A | N/A | N/A |
Dr. Robert Hawkins MBBS, Ph.D. | Head of Research & Development | 218,72k | N/A | N/A |
Instil Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing a pipeline of novel therapies. The company develops cell therapy of tumor infiltrating lymphocyte (TIL) for the treatment of cancer. It is developing early-stage pipeline of CoStAR-TIL and other novel TIL technologies. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
El ISS Governance QualityScore de Instil Bio, Inc., a día 1 de mayo de 2024, es 9. Las puntuaciones base son Auditoría: 8; Tablero: 8; Derechos de los accionistas: 8; Compensación: 9.